Arteria Capital
The name Arteria comes from the Greek, Latin, and Spanish word for artery — a vital vessel that carries oxygenated blood from the heart to the body, enabling movement and connection. Today's healthcare system suffers from a lack of true arteries. Despite decades of innovation, U.S. healthcare remains fragmented, inefficient, and constrained by disconnected workflows. For those early stage AI-enabled healthcare companies trying to solve these problems, true value-added financing is difficult to find. Arteria Capital was created to solve this problem.
Investing activity
Arteria Capital appears in 1 AI deal tracked by the AI Lounge deals desk, and led 1 of them. The rounds are mostly Seed, with a median round size of $7M. The most recent is Provect AI (Seed, $7M, Jul 2026).
Arteria Capital most often invests alongside ValueStream Ventures, Telegraph Hill Capital, Sand Hill Angels and Newfund, and the companies it backs on AI Lounge are mostly in AI.
Deals
Frequently asked questions about Arteria Capital
What AI companies has Arteria Capital invested in?
Arteria Capital's AI investments include Provect AI. The 1 round on AI Lounge are listed on this page with amounts, dates and co-investors.
What stage does Arteria Capital invest at?
In the rounds tracked on AI Lounge, Arteria Capital has invested at Seed, with a median round of $7M. Arteria Capital led 1 of those rounds.
Who does Arteria Capital co-invest with?
Arteria Capital's most frequent co-investors on AI Lounge are ValueStream Ventures (1 deal), Telegraph Hill Capital (1 deal), Sand Hill Angels (1 deal) and Newfund (1 deal).
How can founders reach Arteria Capital?
Founders on AI Lounge can see Arteria Capital's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add Arteria Capital to their Investor Pipeline to track the conversation.